Literature DB >> 19109199

Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis.

Philip L Simonian1, Christina L Roark, Fabian Wehrmann, Allison K Lanham, Fernando Diaz del Valle, Willi K Born, Rebecca L O'Brien, Andrew P Fontenot.   

Abstract

Hypersensitivity pneumonitis is an environmental lung disease characterized by a diffuse mononuclear cell infiltrate in the lung that can progress to pulmonary fibrosis with chronic exposure to an inhaled Ag. Using a well-established murine model of hypersensitivity pneumonitis, we repeatedly exposed C57BL/6 mice to Saccharopolyspora rectivirgula to investigate whether T cells are required for lung fibrosis. In the absence of alphabeta T cells, TCRbeta(-/-) mice exposed to S. rectivirgula for 4 wk had markedly decreased mononuclear infiltrates and collagen deposition in the lung compared with wild-type C57BL/6 mice. In contrast to CD8(+) T cells, adoptive transfer of CD4(+) T cells reconstituted the S. rectivirgula-induced inflammatory and fibrotic response, suggesting that the CD4(+) T cell represents the critical alphabeta T cell subset. Cytokine analysis of lung homogenates at various time points after S. rectivirgula exposure failed to identify a predominant Th1 or Th2 phenotype. Conversely, IL-17 was found in the lung at increasing concentrations with continued exposure to S. rectivirgula. Intracellular cytokine staining revealed that 14% of CD4(+) T cells from the lung of mice treated with S. rectivirgula expressed IL-17A. In the absence of IL-17 receptor signaling, Il17ra(-/-) mice had significantly decreased lung inflammation and fibrosis compared with wild-type C57BL/6 mice. These data are the first to demonstrate an important role for Th17-polarized CD4(+) T lymphocytes in the immune response directed against S. rectivirgula in this murine model of hypersensitivity pneumonitis and pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19109199      PMCID: PMC2766086     

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.

Authors:  Akira Andoh; Shigeki Bamba; Yoshihide Fujiyama; Mairi Brittan; Nicholas A Wright
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey.

Authors:  Y Yoshizawa; Y Ohtani; H Hayakawa; A Sato; M Suga; M Ando
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

4.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.

Authors:  Heon Park; Zhaoxia Li; Xuexian O Yang; Seon Hee Chang; Roza Nurieva; Yi-Hong Wang; Ying Wang; Leroy Hood; Zhou Zhu; Qiang Tian; Chen Dong
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

5.  Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Authors:  C Doucet; D Brouty-Boyé; C Pottin-Clémenceau; G W Canonica; C Jasmin; B Azzarone
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

7.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

8.  IFN-gamma production by innate immune cells is sufficient for development of hypersensitivity pneumonitis.

Authors:  Stephanie Nance; Richard Cross; Ae-Kyung Yi; Elizabeth A Fitzpatrick
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  IL-12 modulates expression of hypersensitivity pneumonitis.

Authors:  G Gudmundsson; M M Monick; G W Hunninghake
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

View more
  77 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

Review 2.  The role of the acquired immune response in systemic sclerosis.

Authors:  Carlo Chizzolini; Francesco Boin
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 3.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

4.  Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis.

Authors:  Philip L Simonian; Christina L Roark; Willi K Born; Rebecca L O'Brien; Andrew P Fontenot
Journal:  Transl Res       Date:  2009-09-09       Impact factor: 7.012

Review 5.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

Review 6.  Immune responses to airborne fungi and non-invasive airway diseases.

Authors:  Gaëlle Vacher; Hélène Niculita-Hirzel; Thierry Roger
Journal:  Semin Immunopathol       Date:  2014-12-13       Impact factor: 9.623

Review 7.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

Review 8.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

Review 9.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

10.  Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.

Authors:  Rogério S Rosada; Ana P Moreira; Fabiani G Frantz; Raj K Puri; Aquilur Rahman; Theodore J Standiford; Carlos R Zárate-Bladés; Célio L Silva; Cory M Hogaboam
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.